当前位置:首页 - 行情中心 - 瑞康医药(002589) - 财务分析 - 现金流量表

瑞康医药

(002589)

  

流通市值:38.51亿  总市值:42.43亿
流通股本:13.66亿   总股本:15.05亿

现金流量表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金5,497,702,516.683,706,109,894.431,882,424,602.097,891,061,764.25
  客户存款和同业存放款项净增加额---0
  向中央银行借款净增加额---0
  向其他金融机构拆入资金净增加额---0
  收到原保险合同保费取得的现金---0
  收到再保险业务现金净额---0
  保户储金及投资款净增加额---0
  收取利息、手续费及佣金的现金---0
  拆入资金净增加额---0
  回购业务资金净增加额---0
  收到的税费返还0-07,099,709.68
  收到其他与经营活动有关的现金369,186,575.85193,922,105.3787,892,457.47307,955,980.87
  经营活动现金流入的其他项目---0
  经营活动现金流入小计5,866,889,092.533,900,031,999.81,970,317,059.568,206,117,454.8
  购买商品、接受劳务支付的现金4,979,898,669.83,245,775,074.71,762,239,1986,803,688,542.71
  客户贷款及垫款净增加额---0
  存放中央银行和同业款项净增加额---0
  支付原保险合同赔付款项的现金---0
  支付利息、手续费及佣金的现金---0
  支付保单红利的现金---0
  支付给职工以及为职工支付的现金198,918,874.13132,147,310.0271,456,107.29294,047,562.04
  支付的各项税费100,252,494.169,863,477.139,415,965.57142,563,410.59
  支付其他与经营活动有关的现金578,676,175.11403,528,224.6694,988,863.72952,058,412.38
  经营活动现金流出的其他项目---0
  经营活动现金流出小计5,857,746,213.143,851,314,086.481,968,100,134.588,192,357,927.72
  经营活动产生的现金流量净额9,142,879.3948,717,913.322,216,924.9813,759,527.08
二、投资活动产生的现金流量:
  收回投资收到的现金---0
  取得投资收益收到的现金26,108,492.45840,838.141,572,693.15597,850.3
  处置固定资产、无形资产和其他长期资产收回的现金净额2,255,771.871,279,718.47685,769.75532,730.14
  处置子公司及其他营业单位收到的现金净额54,722,471.6351,974,218.7815,022,608.4781,840,460.14
  收到的其他与投资活动有关的现金1,435,150,000850,000,000350,000,0001,615,420,000
  投资活动现金流入小计1,518,236,735.95904,094,775.39367,281,071.371,698,391,040.58
  购建固定资产、无形资产和其他长期资产支付的现金44,128,663.0118,073,243.4911,145,29426,820,905.24
  投资支付的现金108,100,000100,000,000100,000,000120,000,000
  质押贷款净增加额---0
  取得子公司及其他营业单位支付的现金--00
  支付其他与投资活动有关的现金1,449,020,000855,000,000350,000,0001,603,371,902.07
  投资活动现金流出小计1,601,248,663.01973,073,243.49461,145,2941,750,192,807.31
  投资活动产生的现金流量净额-83,011,927.06-68,978,468.1-93,864,222.63-51,801,766.73
三、筹资活动产生的现金流量:
  吸收投资收到的现金--020,000,000
  其中:子公司吸收少数股东投资收到的现金--020,000,000
  取得借款收到的现金3,003,635,320.532,537,575,720.531,306,688,4003,361,178,255.69
  收到其他与筹资活动有关的现金12,675,512,186.117,732,256,916.553,016,499,781.5217,466,819,244.03
  筹资活动现金流入小计15,679,147,506.6410,269,832,637.084,323,188,181.5220,847,997,499.72
  偿还债务支付的现金2,637,972,149.831,959,931,778.84964,441,191.73,679,002,430.67
  分配股利、利润或偿付利息支付的现金154,767,134.23118,691,573.677,831,827.04245,569,898.23
  其中:子公司支付给少数股东的股利、利润68,144,384.368,144,384.3071,070,616.28
  支付其他与筹资活动有关的现金13,044,023,565.547,984,239,617.892,988,136,649.3316,857,466,870.27
  筹资活动现金流出小计15,836,762,849.610,062,862,970.334,030,409,668.0720,782,039,199.17
  筹资活动产生的现金流量净额-157,615,342.96206,969,666.75292,778,513.4565,958,300.55
四、汇率变动对现金及现金等价物的影响---0
五、现金及现金等价物净增加额-231,484,390.63186,709,111.97201,131,215.827,916,060.9
  加:期初现金及现金等价物余额718,238,986.97718,238,986.97718,238,986.97690,322,926.07
  期末现金及现金等价物余额486,754,596.34904,948,098.94919,370,202.77718,238,986.97
补充资料:
  净利润-30,336,863.47-43,902,130.25
  资产减值准备--35,843,573.03-26,501,315.05
  固定资产和投资性房地产折旧-52,298,287.8-111,981,410.17
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-52,298,287.8-111,981,410.17
  无形资产摊销-22,600,509.71-64,798,703.77
  长期待摊费用摊销-5,945,471.1-16,704,632.15
  处置固定资产、无形资产和其他长期资产的损失--188,559.16--1,817,272.56
  固定资产报废损失-8,520.18-707,229.23
  公允价值变动损失----4,902,905.63
  财务费用-94,896,124.55-186,867,399.22
  投资损失--6,013,442.28--84,806,805.99
  递延所得税-7,364,759.13--40,373,226.76
  其中:递延所得税资产减少-9,565,465.36--36,834,552.13
    递延所得税负债增加--2,200,706.23--3,538,674.63
  存货的减少-83,871,359.26-15,804,643
  经营性应收项目的减少-83,739,172.27-439,059,669.3
  经营性应付项目的增加--290,819,304.67--763,019,695.96
  现金的期末余额-904,948,098.94-718,238,986.97
  减:现金的期初余额-718,238,986.97-690,322,926.07
  现金及现金等价物的净增加额-186,709,111.97-27,916,060.9
公告日期2026-10-272026-08-212026-04-252026-04-23
审计意见(境内)标准无保留意见
TOP↑